"My hope is also that if psilocybin-assisted therapy is approved as an intervention for depression by the FDA in 2027, then having a better quality of life would also translate into a longer, healthier life." The study was initiated at Emory University and funded by several awards, including the Imagine, Innovative, and Impact (I3) Award, Emory University School of Medicine
By law, that list exists specifically for substances that aren't approved
Therefore, when researchers compare options in this category, GHK-Cu typically stands out for the depth of available scientific literature, structural simplicity, and reproducibility of research findings
However, the efficacy of topical glutathione can vary, as it may not penetrate deeply enough to deliver significant antioxidant benefits